Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)piperazine
2. Aphilan
3. Bucladin-s
4. Buclizine
5. Buclizine Hydrochloride
6. Softran
1. 129-74-8
2. Buclizine Hydrochloride
3. Longifene
4. Buclizine Hcl
5. Buclina
6. Softran
7. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine Dihydrochloride
8. Buclizine, Dihydrochloride
9. Bucladin-s
10. Aphilan
11. Buclodin
12. Ucb 4445
13. Aphilan R
14. Bucladin
15. Buclizine Hydrochloride [usan]
16. Vibazine Hydrochloride
17. Ucb-4445
18. Vibazine
19. Histabutyzine Hydrochloride
20. Histabutyzine Dihydrochloride
21. Buclizine (dihydrochloride)
22. Eop5593fph
23. V4oce982yu
24. 58fqd093nu
25. Buclizine Hydrochloride, (+)-
26. Buclizine Hydrochloride, (-)-
27. Chebi:61193
28. 1-(p-chlorobenzhydryl)-4-(p-t-butylbenzyl)diethylenediamine Dihydrochloride
29. 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)piperazine Dihydrochloride
30. 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride
31. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride
32. Postafeno
33. A 7668
34. Bucladin S
35. Nsc-25141
36. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)-(phenyl)methyl)piperazine Dihydrochloride
37. Buclizine Hydrochloride (usan)
38. 1-(p-tert-butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine Dihydrochloride
39. Buclizine 2hcl
40. 163837-35-2
41. 163837-36-3
42. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride, (+)-
43. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride, (-)-
44. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Hydrochloride (1:2)
45. Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-, Dihydrochloride
46. Einecs 204-962-4
47. Nsc 25141
48. Unii-58fqd093nu
49. Vibazine (tn)
50. 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)piperazine Dihydrochloride
51. 1-p-chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine Dihydrochloride
52. Unii-eop5593fph
53. Unii-v4oce982yu
54. Dsstox_cid_25091
55. Dsstox_rid_80665
56. Dsstox_gsid_45091
57. Schembl123751
58. Chembl2360580
59. Dtxsid5045091
60. Perlapine, >=98% (hplc)
61. Hy-a0128a
62. Bcp22428
63. Tox21_110023
64. Mfcd00242700
65. S4140
66. Buclizine Dihydrochloride [mi]
67. 5-isopropyl-2-methoxyphenylboronicacid
68. Akos016004771
69. Bcp9000459
70. Buclizine Hydrochloride [mart.]
71. Buclizine Hydrochloride [vandf]
72. Ks-1250
73. Buclizine Hydrochloride [who-dd]
74. Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)-, Dihydrochloride
75. Ncgc00013315-01
76. Ac-32891
77. Cas-129-74-8
78. Bcp0726000050
79. Buclizine Dihydrochloride, >=98% (hplc)
80. Buclizine Hydrochloride [orange Book]
81. Cs-0019690
82. Ft-0663892
83. D02089
84. 129b748
85. J-005711
86. Q27130875
87. (rs)-1-(4-t-butylbenzyl)-4-(4-chlorobenzhydryl) Piperazine Dihydrochloride
88. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazinedihydrochloride
89. 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine Dihydrochloride
90. 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazinediium Dichloride
91. 7139-55-1
Molecular Weight | 505.9 g/mol |
---|---|
Molecular Formula | C28H35Cl3N2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 504.186582 g/mol |
Monoisotopic Mass | 504.186582 g/mol |
Topological Polar Surface Area | 6.5 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 514 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Buclizine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buclizine Hydrochloride, including repackagers and relabelers. The FDA regulates Buclizine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buclizine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Buclizine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Buclizine Hydrochloride supplier is an individual or a company that provides Buclizine Hydrochloride active pharmaceutical ingredient (API) or Buclizine Hydrochloride finished formulations upon request. The Buclizine Hydrochloride suppliers may include Buclizine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Buclizine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Buclizine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Buclizine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Buclizine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Buclizine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Buclizine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Buclizine Hydrochloride USDMF includes data on Buclizine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Buclizine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Buclizine Hydrochloride suppliers with USDMF on PharmaCompass.
A Buclizine Hydrochloride written confirmation (Buclizine Hydrochloride WC) is an official document issued by a regulatory agency to a Buclizine Hydrochloride manufacturer, verifying that the manufacturing facility of a Buclizine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Buclizine Hydrochloride APIs or Buclizine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Buclizine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Buclizine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Buclizine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Buclizine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Buclizine Hydrochloride GMP manufacturer or Buclizine Hydrochloride GMP API supplier for your needs.
A Buclizine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Buclizine Hydrochloride's compliance with Buclizine Hydrochloride specifications and serves as a tool for batch-level quality control.
Buclizine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Buclizine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Buclizine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Buclizine Hydrochloride EP), Buclizine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Buclizine Hydrochloride USP).
LOOKING FOR A SUPPLIER?